Commentary on "phase II study of sequential treatment of advanced non-small-cell lung cancer: Three cycles of high-dose epirubicin plus cisplatin followed by weekly vinorelbine"

M. J. Edelman

doi:10.1016/S1525-7304(11)70753-7

Commentary on "phase II study of sequential treatment of advanced non-small-cell lung cancer: Three cycles of high-dose epirubicin plus cisplatin followed by weekly vinorelbine"

M. J. Edelman

University of Maryland

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	47-48
Number of pages	2
Journal	Clinical Lung Cancer
Volume	3
Issue number	1
DOIs	https://doi.org/10.1016/S1525-7304(11)70753-7
State	Published - 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S1525-7304(11)70753-7

Cite this

@article{3349f25c368c42eaa7c0a305626fba5e,

title = "Commentary on {"}phase II study of sequential treatment of advanced non-small-cell lung cancer: Three cycles of high-dose epirubicin plus cisplatin followed by weekly vinorelbine{"}",

author = "Edelman, \{M. J.\}",

year = "2001",

doi = "10.1016/S1525-7304(11)70753-7",

language = "English",

volume = "3",

pages = "47--48",

journal = "Clinical Lung Cancer",

issn = "1525-7304",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Commentary on "phase II study of sequential treatment of advanced non-small-cell lung cancer

T2 - Three cycles of high-dose epirubicin plus cisplatin followed by weekly vinorelbine"

AU - Edelman, M. J.

PY - 2001

Y1 - 2001

UR - https://www.scopus.com/pages/publications/0034800457

U2 - 10.1016/S1525-7304(11)70753-7

DO - 10.1016/S1525-7304(11)70753-7

M3 - Comment/debate

AN - SCOPUS:0034800457

SN - 1525-7304

VL - 3

SP - 47

EP - 48

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

IS - 1

ER -

Commentary on "phase II study of sequential treatment of advanced non-small-cell lung cancer: Three cycles of high-dose epirubicin plus cisplatin followed by weekly vinorelbine"

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this